# US 2019/0316191 A1 · Emulsion chemistry for encapsulated droplets

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316191 A1
- Document ID: US20190316191A1
- Status: Published application
- Kind: A1
- Application number: 16/447,315
- Filed: 2019-06-20
- Published: 2019-10-17
- Earliest claimed: 2010-03-02
- Assignees: Bio-Rad Laboratories, Inc.
- Applicants: Bio-Rad Laboratories, Inc.
- Inventors: Amy L. HIDDESSEN; Benjamin J. HINDSON
- Web page: https://patentgrep.com/patent/US20190316191A1

## CPC

- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6846: {Common amplification features}
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

System, including methods, apparatus, compositions, and kits, for making and using a stabilized emulsion. A method of generating a stabilized emulsion is provided. In the method, an aqueous phase may be provided. The aqueous phase may include an effective concentration of one or more skin-forming proteins. An emulsion may be formed. The emulsion may include droplets of a dispersed phase disposed in a continuous phase, with the aqueous phase being the continuous phase or the dispersed phase. The emulsion may be heated to create an interfacial skin between each droplet and the continuous phase, to transform the droplets into capsules.

## Claims

### Claim 1

A stabilized emulsion, comprising:
a continuous phase comprising a fluorinated oil and at least one anionic surfactant; and
a plurality of capsules disposed in the continuous phase, each capsule including a proteinaceous, interfacial skin encapsulating an aqueous phase.

### Claim 2 (depends on 1)

The stabilized emulsion of claim 1, wherein the anionic surfactant is a fluorinated anionic surfactant.

### Claim 3 (depends on 2)

The stabilized emulsion of claim 2, wherein the fluorinated anion surfactant is polyfluorinated or perfluorinated or both.

### Claim 4 (depends on 1)

The stabilized emulsion of claim 1, wherein the anionic surfactant is an carboxylic acid-terminated perfluoropolyether, a carboxylate salt of a perfluoropolyether, or an amide or ester of a carboxylic acid-terminated perfluoropolyether.

### Claim 5 (depends on 1)

The stabilized emulsion of claim 1, wherein the anionic surfactant is at a concentration of 0.02% to 10% by weight.

### Claim 6 (depends on 1)

The stabilized emulsion of claim 1, wherein the continuous phase comprises a second surfactant.

### Claim 7 (depends on 6)

The stabilized emulsion of claim 6, wherein the second surfactant is a fluorinated alcohol with only one or two hydroxyl groups.

### Claim 8 (depends on 7)

The stabilized emulsion of claim 7, wherein the fluorinated alcohol is perfluorodecanol or perfluorooctanol.

### Claim 9 (depends on 1)

The stabilized emulsion of claim 1, wherein the aqueous phase comprises a sample comprising a nucleic acid.

### Claim 10 (depends on 9)

The stabilized emulsion of claim 9, wherein the aqueous phase comprises a polymerase.

### Claim 11 (depends on 1)

The stabilized emulsion of claim 1, wherein the proteinaceous skin includes at least one protein selected from the group consisting of albumin, casein, gelatin, and globulin. Wherein the protein is at a concentration of 0.05-2% by weight.

### Claim 12 (depends on 1)

The stabilized emulsion of claim 1, wherein the plurality of capsules contain an indicator dye.
